Anoro Ellipta is a brand-name inhaler that’s prescribed for long-term chronic obstructive pulmonary disease (COPD) treatment. Anoro Ellipta contains the active ingredients vilanterol and umeclidinium.
Recently, the U.S. Food and Drug Administration (FDA) approved the supplemental new drug application for Trelegy Ellipta for the maintenance treatment of asthma in patients ages 18 years and older.
Verywell Health on MSN
Don’t combine these COPD medicines
Check this table to make sure you can use your COPD inhalers together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results